|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 330 N. Wabash Avenue, Chicago |
State | IL |
Zip Code | 60611 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III |
Date | 04/18/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1180, "Resident Physician Shortage Reduction Act of 2013," all provisions
S. 577, "Resident Physician Shortage Reduction Act of 2013," all provisions
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3750, "Telehealth Modernization Act of 2013," all provisions
H.R. 1701, "Cutting Costly Codes Act of 2013," all provisions
S. 972, "Cutting Costly Codes Act of 2013," all provisions
H.R. 2194, "Family and Retirement Health Investment Act of 2013," all provisions
H.R. 4169, "Stop Overdose Stat Act (SOS)," all provisions
H.R. 3742, "Antibiotic Development to Advance Patient Treatment Act of 2013," all provisions
ACA implementation
Health Exchanges
ACA's 90-day grace period
Pain Management
Prescription drug abuse and diversion
Prescriber education and mandatory/voluntary CME training
Hydrocodone rescheduling
Photoshopping
Limited Regulation Antibiotic Drugs
Reauthorization of Emergency Medical Services for Children Program (EMSC)
Sunshine Act Regulations
Telemedicine
Price transparency
Quality
Prescription requirements for OTC medications
Electronic Health Records - Meaningful Use Regulations
ICD-10 repeal
HITECH
Diabetes chronic care
HIPAA
EHR data lock-in
Mental health care
Hospital Consolidation
Delivery and payment reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Drug Enforcement Administration (DEA), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
trujillo |
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matt |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
President's FY2015 Budget - Pediatric Subspecialty Loan Repayment
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014," all provisions
S. 2000, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014," all provisions
H.R. 4302, "Protecting Access to Medicare Act of 2014," all provisions
S. 2157, "Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014," all provisions
S. 2122, "Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014," all provisions
S. 2110, "Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014," all provisions
H.R. 2810, "Medicare Patient Access and Quality Improvement Act of 2013," all provisions
S. 1871, "SGR Repeal and Medicare Beneficiary Access Act of 2013," all provisions
S. 540, "Temporary Debt Limit Extension Act," all provisions
H.R. 1180, "Resident Physician Shortage Reduction Act of 2013," all provisions
S. 577, "Resident Physician Shortage Reduction Act of 2013," all provisions
H.R. 1701, "Cutting Costly Codes Act of 2013," all provisions
S. 972, "Cutting Costly Codes Act of 2013," all provisions
H.R. 1179, "Improving Access to Medicare Coverage Act of 2013," all provisions
S. 569, "Improving Access to Medicare Coverage Act of 2013," all provisions
H.R. 1024, "Medication Therapy Management Empowerment Act of 2013," all provisions
H.R. 4190, "To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services," all provisions
H.R. 3890, "Better Care, Lower Cost Act," all provisions
S. 1932, "Better Care, Lower Cost Act," all provisions
H.R. 962, "Medicare Diabetes Prevention Act of 2013," all provisions
S. 452, "Medicare Diabetes Prevention Act of 2013," all provisions
H.R. 3698, "Two-Midnight Rule Delay Act of 2013," all provisions
H.R. 3077, "TELEmedicine for MEDicare Act of 2013," all provisions
Medicare program - Private Contracting
Medicare program - Quality measure development
Medicare program - Value-Based Modifier
Medicare program - SGR Repeal
Medicare program - Independent Payment Advisory Board (IPAB) repeal
Medicare program - Relative Value Scale Update Committee (RUC)
Medicare program - Claims data release
Medicare program - Observation care/two midnights policy/site neutral inpatient/outpatient care
Medicare program - Timing of annual payment changes
Medicare program - Cost measures
Medicare program - Quality and Resource Use Reports
Medicare program - 2015 physician update
Medicare program - Payment reform
Medicare program - Impact of sequester cuts on physicians
Medicare program - 90-day grace period
Medicare program - Appeals backlog
Medicare program - Molecular pathology diagnostics
Medicare program - Alternative payment models
Medicare program - Graduate Medical Education
Medicare program - Diabetes
Medicare program - In-office Ancillary Services Exception
Medicare program - Recovery Audit Contractors (RACs)
Medicare program - Consolidation of audits
Medicare program - Program Integrity
Medicare program - Exchanges
Medicare program - Mopath Codes
Medicare program - CPT
Medicare program - Medicare Advantage
Medicare program - Narrow networks
Medicare and Medicaid programs - Electronic Health Records/Meaningful Use Regulations
Medicare and Medicaid programs - ICD-10 Repeal
Medicare and Medicaid programs - Mental health care
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Government Accountability Office (GAO), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matt |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Mari |
Savickis |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1733, "Good Samaritan Health Professionals Act of 2013," all provisions
S. 2196, "Good Samaritan Health Professionals Act of 2014," all provisions
H.R. 1473, "Standard of Care Protection Act of 2013," all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 3391, "Indian Health Service Health Professions Tax Fairness Act of 2013," all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Design and composition of cigarettes
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 2131, "SKILLS Visa Act," all provisions
S. 744, "Border Security, Economic Opportunity, and Immigration Modernization Act," provisions relating to physician immigration issues
S. 616, "Conrad State 30 and Physician Access Act," all provisions
H.R. 3903, "Foreign Medical School Accountability Fairness Act of 2014," all provisions
S. 1822, "Foreign Medical School Accountability Fairness Act of 2013," all provisions
Medical Licensure
Antitrust
Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |